Research in the Tumor Imaging Program extends from imaging in animals geared towards helping expand our understanding of cancer biology, to the use of medical imaging on the diagnosis and assessment of response to therapy of tumors. The overall goal of the members of this program is to develop new approaches to use medical imaging in cancer research and to extend current imaging capabilities to optimize diagnosis and assessment of response to therapy. There are five major overlapping themes within the umbrella of the Program's research. Theme 1 - Diagnostic Imaging Theme 2 - Assessment of Response to Therapy by Imaging Theme 3 - Reporter Gene Imaging Theme 4 - Imaging Parameters Indicative of Metabolic Oxidative Stress Theme 5 - Imaging of Cell Trafficking Major accomplishments of the Tumor Imaging Program include (a) Discovery that 2DG-induced radiosensitization involved disruptions in thiol metabolism supporting the hypothesis that metabolic oxidative stress could be involved with the therapeutic effects of 2DG during cancer therapy, (b) Discovery that gene therapy using an adenovirus vector containing a cDNA coding for the sodium iodide symporter could be utilized to concentrate radionuclides in tumors, and (c) Significant contributions to our understanding of lung cancer diagnosis extending from development of novel approaches to lung cancer imaging through extensive participation in the lung cancer early detection trial. There are numerous past and present productive collaborations both between members of the Program, and with members of other Cancer Center programs. The interactive nature of the Program is illustrated by the """"""""Molecular Imaging of Responses to Cancer Therapy"""""""" program supported by an NCI P20 and successful shared instrumentation grants to obtain a Micro- PET machine and SPECT-CT. The program consists of 25 members from 7 departments and 2 colleges. Peer-reviewed, research funding for this program totals $5,878,362 with $1,486,243 coming from the NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-10
Application #
7900744
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-07-01
Project End
2010-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
10
Fiscal Year
2009
Total Cost
$22,489
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Mayo, Zachary; Seyedin, Steven; Marquardt, Michael et al. (2018) Cutaneous malignant melanoma of the oral cavity following skin graft reconstruction: Case report. Head Neck :
D'Angelo, Sandra P; Mahoney, Michelle R; Van Tine, Brian A et al. (2018) Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. Lancet Oncol 19:416-426
McMaster, Mary L; Berndt, Sonja I; Zhang, Jianqing et al. (2018) Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia. Nat Commun 9:4182
Beck, Anna C; Goffredo, Paolo; Hassan, Imran et al. (2018) Risk factors for 30-day readmission after adrenalectomy. Surgery 164:766-773
Gorman, Jacob V; Colgan, John D (2018) Acute stimulation generates Tim-3-expressing T helper type 1 CD4 T cells that persist in vivo and show enhanced effector function. Immunology 154:418-433
El-Galaly, Tarec Christoffer; Cheah, Chan Yoon; Bendtsen, Mette Dahl et al. (2018) Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma. Eur J Cancer 93:57-68
Fama, Angelo; Xiang, Jinhua; Link, Brian K et al. (2018) Human Pegivirus infection and lymphoma risk and prognosis: a North American study. Br J Haematol 182:644-653
Xiu, Yan; Dong, Qianze; Li, Qingchang et al. (2018) Stabilization of NF-?B-Inducing Kinase Suppresses MLL-AF9-Induced Acute Myeloid Leukemia. Cell Rep 22:350-358
Armer, Jessica S; Clevenger, Lauren; Davis, Lauren Z et al. (2018) Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer. Cancer 124:3401-3408
Spencer Noakes, T Leigh; Przybycien, Thomas S; Forwell, Amanda et al. (2018) Brain Development and Heart Function after Systemic Single-Agent Chemotherapy in a Mouse Model of Childhood Leukemia Treatment. Clin Cancer Res 24:6040-6052

Showing the most recent 10 out of 1080 publications